Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Cancer”

6,908 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,908 results

Testing effectiveness (Phase 2)Study completedNCT01797900
What this trial is testing

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Who this might be right for
Nasopharyngeal Neoplasms
Chinese Academy of Medical Sciences 130
Testing effectiveness (Phase 2)Looking for participantsNCT03128034
What this trial is testing

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia+9 more
Fred Hutchinson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Large-scale testing (Phase 3)Not Yet RecruitingNCT06927232
What this trial is testing

AZA+Lus VS AZA Monotherapy in HR-MDS

Who this might be right for
Higher-risk Myelodysplastic Syndrome
Peking Union Medical College Hospital 86
Early research (Phase 1)Study completedNCT03042793
What this trial is testing

Vaccination With PD-L1 Peptide Against Multiple Myeloma

Who this might be right for
Multiple Myeloma
Lene Meldgaard Knudsen 10
Testing effectiveness (Phase 2)UnknownNCT01914458
What this trial is testing

Image Discovering Early Lung Cancer Project

Who this might be right for
Lung Cancer
Cathay General Hospital 600
Not applicableLooking for participantsNCT05954858
What this trial is testing

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Who this might be right for
Glioma, MalignantGlioblastomaGlioblastoma Multiforme+4 more
Northwell Health 32
Not applicableStudy completedNCT02629458
What this trial is testing

Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection

Who this might be right for
Oncology
The Leeds Teaching Hospitals NHS Trust 54
Early research (Phase 1)Study completedNCT00569985
What this trial is testing

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Large-scale testing (Phase 3)UnknownNCT02773485
What this trial is testing

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Tata Memorial Hospital 155
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Early research (Phase 1)Ended earlyNCT01957644
What this trial is testing

Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Boehringer Ingelheim 16
Testing effectiveness (Phase 2)Study completedNCT02864147
What this trial is testing

Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical Dysplasia
Yale University 134
Early research (Phase 1)Study completedNCT00005835
What this trial is testing

N99-02: Melphalan and Buthionine Sulfoximine

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 31
Early research (Phase 1)Looking for participantsNCT04428671
What this trial is testing

Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

Who this might be right for
Metastatic Skin Squamous Cell CarcinomaRecurrent Skin Squamous Cell Carcinoma
Emory University 20
Not applicableNot Yet RecruitingNCT07260344
What this trial is testing

Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral Precancer

Who this might be right for
Oral PrecancerOral CancerOral Cancer Screening
Anil Chaturvedi 400
Testing effectiveness (Phase 2)Study completedNCT00053287
What this trial is testing

Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 42
Not applicableLooking for participantsNCT05945121
What this trial is testing

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplant
University of Michigan Rogel Cancer Center 10
Large-scale testing (Phase 3)Active Not RecruitingNCT05943106
What this trial is testing

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Who this might be right for
Non-Muscle- Invasive Bladder Cancer
AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT00204633
What this trial is testing

Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)

Who this might be right for
Dysgerminoma
University Hospital Tuebingen 108
Load More Results